🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 11% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Tablet(s) Serving Size
45 Servings
Other Combinations Product Type
11% Evidence Coverage

Supplement Facts — Evidence Check

Total Carbohydrates
1 Gram(s) (1% DV)
20 mg (125% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
310 mg
📊 Market median: 496.0mg (192 products) 📚 20 studies — no high-quality reviews
This product: 310mg
L-Glutamic Acid
310 mg
200 mg
📊 Market median: 200.0mg (136 products) 📚 3 studies — no high-quality reviews
This product: 200mg
Papain
200 mg
Amylase
150 mg
Lipase
100 mg
Ox Bile
32 mg

Other Ingredients

Cellulose Stearic Acid Sodium Carboxymethylcellulose Silicon Dioxide Hydroxypropyl Methylcellulose Magnesium Stearate Glycerin

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Sugar Free

Product Information

📋 Directions for Use

Recommendation: Take 2 tablets with meals, or as recommended by your healthcare professional.

⚠️ Warnings & Precautions

Caution: Not recommended for use if peptic ulcer, gastritis, or heartburn are present.

If pregnant, nursing, or taking prescription drugs, consult your healthcare professional prior to use.

Keep out of reach of children.

Safety sealed with printed inner seal. Do not use if seal is broken or missing.

Contains milk.

🧪 Formulation Notes

Contains no sugar, salt, yeast, wheat, gluten, soy, artificial colors, flavors, or preservatives.

Contains milk.

Additional Information

LZ71459.D01 BLK145D

Protein Digesting Support

Keep bottle tightly closed in a dry place.

Product Details

UPC / SKU 8 71791 00251 7
DSLD Entry Date 2019-04-25
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 201214
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →